Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
170.16
161.30
95.54
74.82
116.66
111.20
132.84
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
170.16
161.30
95.54
74.82
116.66
111.20
132.84
Raw Material Cost
81.70
71.67
42.73
44.16
51.18
56.24
59.81
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.40
0.06
0.00
0.00
0.01
0.00
0.04
Selling and Distribution Expenses
46.24
54.37
36.19
26.69
39.56
27.38
39.40
Other Expenses
0.34
0.40
0.57
1.50
0.82
0.87
1.23
Total Expenditure (Excl Depreciation)
131.75
130.14
84.66
85.86
98.98
92.29
111.53
Operating Profit (PBDIT) excl Other Income
38.4
31.200000000000003
10.9
-11
17.7
18.9
21.299999999999997
Other Income
8.50
2.21
-12.40
2.76
3.92
6.52
13.67
Operating Profit (PBDIT)
53.99
45.66
-0.78
1.18
30.96
36.40
43.19
Interest
0.40
0.06
0.00
0.00
0.01
0.00
0.04
Exceptional Items
0.16
0.00
-1.14
0.30
-0.04
0.09
0.04
Gross Profit (PBDT)
88.47
89.63
52.81
30.66
65.48
54.96
73.03
Depreciation
13.50
13.50
13.30
13.30
12.84
12.84
13.27
Profit Before Tax
40.26
32.09
-15.22
-11.82
18.07
23.65
29.92
Tax
6.03
2.16
-0.28
-0.44
0.54
0.58
2.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
34.62
30.07
-14.92
-11.21
19.60
23.08
20.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
34.62
30.07
-14.92
-11.21
19.60
23.08
20.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.68
0.46
0.03
-0.17
-0.02
-0.02
-0.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
33.93
30.54
-14.88
-11.38
19.57
23.07
20.72
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
0.0
1.0
1.0
Reserves
1,429.53
1,392.30
1,355.55
1,370.85
1,381.34
1,382.45
1,358.80
Earnings per share (EPS)
0.32
0.28
-0.14
-0.1
0.18
0.21
0.19
Diluted Earnings per share
0.32
0.28
-0.14
-0.1
0.18
0.21
0.19
Operating Profit Margin (Excl OI)
18.8%
18.56%
-1.75%
-19.89%
12.17%
15.33%
12.24%
Gross Profit Margin
31.59%
28.27%
-2.01%
1.97%
26.5%
32.81%
32.51%
PAT Margin
20.34%
18.64%
-15.61%
-14.99%
16.8%
20.76%
15.63%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 45.84% vs 28.38% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 72.96% vs 35.17% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 68.52% vs 104.55% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Shandong Keyuan Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
170.16
0
170.16
Other Operating Income
0.00
0.00
0.00
Total Operating income
170.16
0
170.16
Raw Material Cost
81.70
0
81.70
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.40
0
0.40
Selling and Distribution Expenses
46.24
0
46.24
Other Expenses
0.34
0.00
0.34
Total Expenditure (Excl Depreciation)
131.75
0
131.75
Operating Profit (PBDIT) excl Other Income
38.41
0.00
38.41
Other Income
8.50
0
8.50
Operating Profit (PBDIT)
53.99
0
53.99
Interest
0.40
0
0.40
Exceptional Items
0.16
0
0.16
Gross Profit (PBDT)
88.47
0
88.47
Depreciation
13.50
0
13.50
Profit Before Tax
40.26
0
40.26
Tax
6.03
0
6.03
Provisions and contingencies
0
0
0.00
Profit After Tax
34.62
0
34.62
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
34.62
0
34.62
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.68
0
-0.68
Other related items
0.00
0.00
0.00
Consolidated Net Profit
33.93
0
33.93
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,429.53
0
1,429.53
Earnings per share (EPS)
0.32
0
0.32
Diluted Earnings per share
0.32
0
0.32
Operating Profit Margin (Excl OI)
18.80%
0%
0.00
18.80%
Gross Profit Margin
31.59%
0%
0.00
31.59%
PAT Margin
20.34%
0%
0.00
20.34%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 17.02 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 5.52% vs 68.90% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 45.84% vs 28.38% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.39 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 11.15% vs 304.70% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 72.96% vs 35.17% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.55 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 4.84% vs 274.14% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 68.52% vs 104.55% in Jun 2025
Quarterly - Interest
Interest 0.04 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 300.00% vs 0.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.80%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
